Ferdinand, Keith C. http://orcid.org/0000-0003-3338-4410
Norris, Keith C. http://orcid.org/0000-0003-3071-0700
Rodbard, Helena W. http://orcid.org/0000-0002-6187-8445
Trujillo, Jennifer M. http://orcid.org/0000-0001-7898-8029
Funding for this research was provided by:
Boehringer Ingelheim
Eli Lilly and Company
Article History
Received: 9 June 2023
Accepted: 11 August 2023
First Online: 26 September 2023
Declarations
:
: Keith C. Ferdinand has served as a consultant for Amgen, Boehringer Ingelheim, Eli Lilly and Company, Janssen, and Medtronic. Keith C. Norris has served as a consultant for Atlantis Health Care for quality improvement, and is supported in part by NIH grants UL1TR000124, P30AG021684, and P50MD017366. Helena W. Rodbard has served as a consultant for, and received research support from, Eli Lilly, Novo Nordisk, Sanofi, Medtronic, Merck, Pacira, and Regeneron. Jennifer M. Trujillo has served as a consultant for Novo Nordisk, and Sanofi.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.